Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-3,300
Closed -$904K 399
2018
Q1
$904K Buy
3,300
+3,100
+1,550% +$962K 0.09% 152
2017
Q4
$64K Sell
200
-3,200
-94% -$1.03M 0.01% 349
2017
Q3
$1.06M Buy
3,400
+500
+17% +$148K 0.19% 99
2017
Q2
$787K Buy
+2,900
New +$767K 0.12% 146
2017
Q1
Sell
-1,700
Closed -$482K 222
2016
Q4
$482K Sell
1,700
-1,200
-41% -$356K 0.17% 66
2016
Q3
$908K Sell
2,900
-2,200
-43% -$652K 0.1% 70
2016
Q2
$1.23M Buy
5,100
+5,074
+19,515% +$1.34M 0.05% 215
2016
Q1
$677K Sell
26
-77
-75% -$20.3K 0.03% 274
2015
Q4
$3.15M Buy
103
+16
+18% +$4.6K 0.1% 89
2015
Q3
$2.07M Sell
87
-4,713
-98% -$1.56M 0.02% 106
2015
Q2
$1.94M Buy
4,800
+3,900
+433% +$1.57M 0.04% 172
2015
Q1
$380K Sell
900
-1,900
-68% -$749K 0.01% 469
2014
Q4
$950K Buy
2,800
+400
+17% +$129K 0.02% 326
2014
Q3
$794K Buy
+2,400
New +$791K 0.03% 301

Other funds holding BIIB

Jump Trading's BIIB Position: Q2 2018 in Review

Jump Trading sold out of Biogen (BIIB) in Q2 2018, closing a stake of 1,564 shares — an estimated $428K sold.

Jump Trading first reported a position in BIIB in Q3 2014 and held it in 11 quarters. The position peaked at $1.05M in Q1 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Jump Trading reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Jump Trading sold 1,564 Biogen shares in Q2 2018, an estimated $428K.
  • Jump Trading first reported a position in Biogen in Q3 2014 and held it in 11 quarters.
  • Jump Trading's Biogen position peaked at $1.05M in Q1 2015.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Jump Trading's 13F filing for Q2 2018, filed 14 Aug 2018.